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A number of murine genes significantly affect virus-induced leukemogenesis. 
One of these is linked to the major histocompatibility complex, H-2, and has 
been shown to have a  marked effect on the outcome of infection by murine 
leukemia viruses (MuLV), 1 including Gross, Friend, BALB-Tennant leukemia 
virus, (BT/L) and mammary tumor viruses (MTV) (1). 
The  mechanism  of action  of H-2-1inked  loci  in  these  virus-induced  leukemias  is 
unknown.  Early studies by Lilly (2) showed that Friend virus (FV)  inoculation led to 
rapid splenomegaly (within 6-10 days) regardless of the H-2  haplotype of the infected 
mice.  However, H-2  genotype had a  dramatic effect on the subsequent recovery from 
splenomegaly, suggesting that H-2-1inked loci affected a late stage of FV disease. 
The H-2 complex, and its homologue in man, HLA, have been extensively studied and 
a  vast array of immunologic and nonimmunologic functions have been associated with 
this highly polymorphic multigene complex (for review see reference 3). Availability of 
numerous recombinants has allowed subdivision of the H-2 complex of the mouse into at 
least six regions, K, I, S, G, D, and TLa (see Fig. 1). Furthermore, certain immunological 
functions seem  to  be  preferentially  associated  with  given regions,  although there  is 
considerable overlap in functional associations.  For example,  a  variety of distinct im- 
mune response (Ir) genes, affecting humoral response to a variety of synthetic polypep- 
tides and low doses of natural antigens, have been found to map to the I region of  the H-2 
complex (4). 
Precise genetic mapping of genes affecting resistance or susceptibility to MuLV, might 
therefore,  aid in further understanding the mechanism of H-2-mediated resistance  to 
virus-induced neoplasia.  Precise assignment of H-2-1inked loci affecting viral leukemo- 
genesis has only been possible for FV-induced disease (5), where the locus involved has 
been localized to the D  region. With all other viruses, investigators lacked the required 
recombinant mouse strains for precise genetic localization of the loci involved. Nonethe- 
less,  studies  (6) on the  C3H strain of MTV (C3H/MTV)  suggest a  similar association 
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FIG.  1.  Partial genetic fine structure of mouse chromosome 17, showing the H-2-TLa gene 
complex. This complex is divided into six main regions; K, I, S, G, D,  and TLa.  These 
regions are denoted by marker loci H-2K, Ir-1, Ss(Slp), H-2G, H-2D, and TL. The bound- 
aries  of each  region  are  defined by  intra-H-2  recombinations.  The I  region has  been 
subdivided into five subregions by recombination: A, B, J, E, and C defined by marker loci 
Ir-lA  (Ia-1), Ir-lB,  Ia-4,  Ia-5,  and Ir-lC  (Ia-3),  respectively. According to  definitions 
proposed by Klein et al. [28], the K end of the complex is the segment to the left ofSs. The D 
end is the segment to the right of Ss.  Alleles are alternate genes at defined loci, and 
haplotype specifies the specific combination of all alleles at all loci within the complex 
characterizing a given mouse strain.  Allele and haplotype designations are noted in lower 
case letters,  whereas regions,  subregions, and marker loci  are written with capital  letters. 
The TLa region is subdivided by marker loci  Qa-1 (14),  Qa-2 (15),  and TL (12,  13). 
between susceptibility to oncogenesis and the D  end  (S,  G,  and D  region) of the H-2 
complex. Similar results have been observed studying BT/L leukemogenesis (7). 
It is apparent that at least two distinct genes,  and therefore,  probably two distinct 
modes of action operate within the H-2 complex, in conferring resistance to viral-induced 
leukemogenesis. This is inferred from the early studies of Lilly (8) with Gross virus which 
clearly indicated that genes in the K  end (K and I  regions) of the H-2 complex (not the D 
end) conferred resistance to Gross virus-induced tumorigenesis. 
The present studies show that  resistance or susceptibility to radiation leuke- 
mia  virus  (RadLV)  (9)  is associated with  a  gene(s)  in the D  region of the H-2 
complex. In the accompanying paper it will be fttrther shown that non-H-2 genes 
can override the protection associated with resistant H-2  alleles. These results 
indicate  an  interaction  between  several  possible mechanisms  of resistance  to 
neoplasia mediated  by H-2- and non-H-2-1inked genes. 
Materials and Methods 
Mice.  B10.AQR(nS)  were kindly provided by Dr. Jan Klein, The University of Texas, South- 
western  Medical School,  Dallas,  Texas;  C57BL/6-TL + mice were  generously supplied by Dr. 
Edward A. Boyse, Memorial Sloan-Kettering Cancer Institute, New York; C57BL/10SnSg  and 
B10.BR mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. All other mouse 
strains (Table I) were bred and maintained at Stanford. Since RadLV is a B-tropic virus, all mice 
tested were Fv-1 b. 
Virus.  RadLV preparations were  cell-free extracts obtained from  virus-induced lymphoid 
tumors of C57BL/Ka mice as previously described (9, 10). C57BL/Ka is a substrain of strain C57BL 
(H-2 b) maintained by Dr. Henry S. Kaplan at Stanford University. This substrain is characterized 
by 90-100% lymphoma incidence after whole body irradiation (9, 10). Briefly, thymus, spleen, and 
lymph nodes were removed, pooled, homogenized in phosphate-buffered saline (PBS) to make a 
20% suspension (vol/vol), and centrifuged at 10,000 rpm for 15 rain. The pellet was discarded and 
the extract recentrifuged two additional times. All procedures were carried out in the cold. The 
extract was aliquoted and frozen in liquid nitrogen. 
H-2 Typing of Backcross Progeny.  Contract antiserum D4[(B10.AKM ×  129/J)F,  anti-B10.A] 
directed against H-2D  d determinants, was used to type backcross progeny for H-2 in a hemaggluti- 
nation assay (11). For the hemagglutination assay, PBS containing 1% polyvinylpyrrolidone (lot MERUELO,  LIEBERMAN,  GINZTON,  DEAK,  AND  McDEVITT  1081 
TABLE  I 
Effect of H-2 Genotype on Incidence of Mortality 22 wk after RadLV Intrathymic 
Inoculation 
Mortality 22  No. of mice  H-25 
Strain  wk after virus 
tested 
inoculation*  K  A  B  J  E  C  S  G 
% 
B10.G  93  41  q  q  q  q  q  q  q  q 
B10.S  100  22  s  s  s  s  s  s  s  s 
B10.BR  63  59  k  k  k  k  k  k  k  k 
B10  20§  15  b  b  b  b  b  b  b  b 
B10.T(6R)  9  32  q  q  q  q  q  q  q  i  ?  i  d 
B10.S(7R)  8  39  s  s  s  s  s  s  s  s  t  d 
B10.AQR (nS)  0  7  q  ]  k  k  k  k  d  d  d  d 
B10.A  19  59  k  k  k  k  k  I  d  d  d  d 
B10.A(3R)  0  5  b  b  b  b  f  k  d  d  d  d 
B10.A(SR)  0  13  b  b  b  ]  k  k  d  d  d  d 
B10.A(18R)  0  16  b  b  b  b  b  b  b  t  ? i  d 
B10.HTT  25  16  s  s  s  s  I  k  k  k  k  d 
B10.D2  10  19  d  d  d  d  d  d  d  d  d 
TLa 
q  b 
s  b 
k  a 
b  b 
a 
a 
a 
a 
a 
a 
a 
c 
a 
* Results shown represent the total data from seven experiments. In no case were the results from 
any one experiment significantly different from the results shown except for data shown for B10 
mice. 
Vertical bar indicates crossover location. 
§ Data shown are from most representative experiment. Appreciable variability in susceptibility 
was detected in several experiments. However, the overall data suggest that this haplotype is 
relatively resistant. 
no. 29,  General Aniline & Film Corp., New York) plus 0.1% bovine serum albumin was used to 
make all antiserum dilutions and 0.1 ml of the appropriate antiserum dilution was then mixed 
with 0.05 ml of  a 2% suspension of  mouse erythrocytes, incubated for 2 h at room temperature, and 
read in an illuminated Rh typing box. 
Virus Inoculation.  Animals (3-6 wk of age) were ether anesthetized, and their thymuses were 
exposed and inoculated with 0.05  ml of the virus preparation into each lobe. 
Scoring for Leukernogenesis.  All animals were autopsied at death or when moribund, and 
judged positive if an obvious thymoma had developed. In the few instances in which a thymoma 
was not apparent, microscopic examination was performed  to achieve an unequivocal diagnosis. 
Results 
H-2D  Control  of RadLV-Induced  Leukemogenesis.  As  shown  in  Fig.  2, 
marked differences in latency and final incidence of leukemia can be observed 
among  mice  of different H-2  genotypes  after inoculation  of RadLV.  Strains 
B10.G and B10.S show marked susceptibility to the disease, with most animals 
succumbing 20 wk after intrathymic virus inoculation.  Strains B10.T(6R)  and 
B10.S(7R) show, by comparison, a delayed mortality and a substantially lower 
incidence of leukemia, even as late as 40 wk after RadLV inoculation. As shown 
in the legend of Fig. 2, each resistant strain differs from its susceptible counter- 
part only at the D and TLa regions of the H-2-TLa complex. The H-2D d and TL  a 
alleles are, in both pairs, associated with resistance. 
Additional C57BL/10-derived  H-2 congenic and recombinant strains of mice 
were examined for susceptibility to RadLV-induced leukemogenesis. The major- 
ity of strains examined were observed for a period greater than 39 wk subse- 1082  H-2  CONTROL  OF  RadLV-INDUCED  LEUKEMOGENESIS 
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FIG.  2.  Ability of various H-2 congenic strains of mice to resist leukemogenesis as judged 
by ability to survive neoplasia during a 40 wk period after intrathymic injection of RadLV at 
3-6  wk  of age.  Virus  preparation  and  injection  of mice  was  done  as  described  under 
Materials and Methods. 
quent to virus inoculation.  However, a  22  wk observation period sufficed to 
reflect differences in  susceptibility or resistance observed in  studies  over a 
longer time period. As shown in Table I, all strains examined having the H-2D  d 
allele were markedly resistant to the disease in comparison to strains having 
the susceptible D  region alleles H-2D  q (B10.G) and H-2D  s (B10.S). 
The involvement of the TL  locus in resistance or susceptibility (12, 13)  is 
rendered improbable by the observation (Table I) that B10.BR (TL  a) mice are 
more susceptible to RadLV-induced leukemogenesis than B10  (TLb).  In this 
comparison,  TL"  is  associated  with  susceptibility and  TL  b  with  resistance, 
whereas these alleles  are  in  all  other cases associated with  resistance and 
susceptibility, respectively. Nonetheless, it cannot be argued definitively that 
loci within the segment of chromosome  between TL and D, such as Qa-1  (14) and 
Qa-2  (15) or TL  proper are not involved in conferring resistance to RadLV- 
induced neoplasia. The available TL  congenic strains C57BL/6 and C57BL/6- 
TL"  do not differ significantly in  susceptibility to RadLV-induced neoplasia 
(data not shown). However, this comparison is not informative because these 
congenic mice derive the TLa segment of chromosome from strains B10.A and 
C57BL/6, both of which are resistant strains. Thus, while precise localization of 
resistance to the D region of the complex appears likely, formal mapping must 
await  definitive studies  ruling out the  involvement of loci  within the TLa 
region. 
H-2-Associated  Resistance  is  Inherited  as  a  Dominant  Mendelian 
Trait.  Fig.  3  indicated that  resistance to  RadLV-induced tumorigenesis is MERUELO,  LIEBERMAN,  GINZTON,  DEAK,  AND  McDEVITT 
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Fie.  3.  Resistance to RadLV-induced leukemogenesis  is inherited as a  dominant trait in 
[B10.G  x  B10.T(6R)]F,  mice.  Resistance  to RadLV  disease  is judged  as described  in the 
legend to Fig. 2. Percent survival curves of strains B10.G and B10.T(6R) are replotted from 
Fig. 2 for comparison. 
TABLE  H 
Resistance to RadL V-Induced Neoplasis and H-2 Segregate as Linked 
Traits in Offspring of a [(BIO.G  x  BIO.D2)FI  x  BIO.G] Backcross 
1083 
Mortality 
incidence  No. of  mice 
Mice  H-2 genotype  22 wk after  tested  RadLV in- 
oculation 
% 
[(B10.G  x  B10.D2)FI  x  ~H-2D dl~  19  32 
B10.G]  [H'2D qlq  100  17 
B10.G  H-2D  q~q  93  41 
B10.D2  H-2D  did  10  19 
[B10.G  x  B10.T(6R)]FI  H-2D  dlq  27  33 
inherited as a dominant trait. For example, 22 wk after virus inoculation 93% of 
all B10.G (susceptible) mice are dead of leukemia, whereas only 9% of  B10.T(6R) 
(resistant)  and 27%  of [B10.G  ×  B10.T(6R)]F,  mice  have  died.  Similarly,  in 
parallel studies (although fewer animals were tested), (B10.S  x  B10.A)F, were 
found to be more resistant to RadLV than B10.S mice. In beth cases, however, F~ 
hybrids were slightly more susceptible than the resistant parents. 
A  Backcross Segregation Analysis Establishes Linkage  between H-2D and 
Resistance to RadLV-Induced Leukemogenesis.  Formal proof of linkage be- 
tween  resistance  to  RadLV  and H-2  has  been  obtained  by  carrying  out  a 
backcross segregation analysis. 
(B10.G  ×  B10.D2)F~  hybrids  were mated to B10.G,  and progeny mice H-2 
typed by the hemagglutination assay  (11) and scored in terms of resistance to 
RadLV. Table II shows that H-2  q~q offspring mice were highly susceptible with 
100% mortality by 22 wk after virus inoculation,  whereas H-2  q/d  litter mates 
exhibited'a markedly lower mortality during the same time interval. 1084  I-1-2  CONTROL  OF  RadLV-INDUCED  LEUKEMOGENESIS 
Discussion 
Resistance or susceptibility to RadLV is associated with the D region of  the H- 
2  complex, although it has not been possible to formally rule out the involve- 
ment of loci within the TLa region. The H-2D d allele confers resistance to the 
disease, whereas the H-2D q and H-2D s haplotypes are associated with suscepti- 
bility. H-2-1inked resistance to RedLV appears to be expressed as a dominant 
trait in hybrid offspring of crosses between susceptible and resistant mice. 
There are numerous previous reports associating resistance or susceptibility to 
murine type-C RNA viruses and the m~jor histocompatibility complex, H-2 (1). 
The first evidence concerning the possible mechanism of H-2 genetic control of 
virus-induced leukemogenesis  was obtained by Lilly (2) in studies with FV. H-2 d 
haplotype mice showed a  10-fold lower virus dose threshold for splenomegaly 
induction and were much less prone to recovery from splenomegaly than H-2 b 
mice, indicating that the H-2 haplotype of the hosts appeared to significantly 
alter the course rather than the onset of the disease. 
The clear demonstration of several Ir genes within the highly pelymorphic  H- 
2 complex affecting the humoral response to a variety of synthetic and natural 
antigens (4); the close or identical mapping of resistance to Gross virus-1 (Rgv-1) 
and  such Ir  genes  (8), and the  indication from studies  with  FV  that H-2- 
associated gene(s) might influence a late event in the disease, namely recovery 
from splenomegaly (2), all suggested that the level of immune responsiveness to 
virus-specific or tumor-specific  transplantation antigens might also be regulated 
by Ir genes. This suggestion was supported by the findings of Aoki et al.  (16) 
that mice of the resistant H-2 haplotype showed detectable levels of anti-Gross 
virus antibodies, whereas mice of the susceptible H-2 type showed no detectable 
levels of anti-Gross virus antibodies. In addition, experiments by Sato et al. (17) 
demonstrated that tumor cells from some leukemias derived from BALB/c mice 
were  rejected by  F,  hybrids  of BALB/c  with  other  inbred  strains.  Studies 
utilizing standard genetic tests and a panel of H-2 congenic hybrids established 
that immune responsiveness to the tumor cells was linked to the K end of the H- 
2 complex. Tumor cell rejection was shown to be mediated by a C57BL/6 gene(s) 
conferring  responsiveness to the leukemia-related  transplantation antigen (X.1) 
of MuLV and leukemia cells. 
However, more recent experiments by Chesebro et al. (5) indicate that resist- 
ance to FV is associated with genes in the H-2D  region of the complex. In a 
series of experiments designed to test directly the role of  It genes on FV disease, 
Chesebro and Wehrly (18, 19) found no correlation between H-2  genotype and 
ability to generate either a cell-mediated or humoral response. Both susceptible 
(H-2 ~)  and  resistant (H-2  b)  animals  were  capable  of making vigorous  cell- 
mediated and humoral responses.  However,  using a  different experimental 
system, Blank et al.  (20) have found that resistant mice (H-2  b) can generate a 
cell-mediated  lympholysis  (CML)  response  to  FV-induced,  tissue  culture- 
adapted tumor cells, whereas susceptible animals (H-2  k and H-2 d) cannot. 
While the concept that H-2-1inked immune response genes confer resistance 
to the FV disease remains at the moment uncertain, the mapping of the gene(s) 
conferring resistance to FV to the D region of the complex would suggest that 
additional genes, operating via distinct mechanisms may also be involved in MERUELO,  LIEBERMAN,  GINZTON,  DEAK,  AND  McDEVITT  1085 
affording protection to virus-induced leukemogenesis. (However, Young et al. 
(21) have recently indicated that Jr-type mechanisms mapping to the TL region 
may be  operative  in  the  humoral response  to  ferritin.)  For  example, 1-1-2- 
associated loci are known to affect expression of surface antigens on FV-infected 
spleen cells (22). While such changes in antigen expression may result from FV 
infection and be unrelated to the mechanism of resistance associated with H-2- 
linked loci, they might also directly affect  H-2-associated mechanisms of resist- 
ance to FV. Recent evidence suggests that ]-1-2- and virus-associated antigens 
may arrange on the cell surface to present a configuration capable of eliciting a 
CML response [23-25]. Such effects on antigen expression or configuration may 
ultimately result in differences in immune responsiveness by mice of different 
H-2  genotypes. Alternatively, changes in cell surface antigen expression may 
alter virus penetration, assembly, or budding at the cell surface. 
Other H-2  effects possibly  affecting virus-induced neoplasia  are  known. 
Freedman and Lilly (26) have found that FV-induced tissue culture cell lines of 
H-2  b origin (resistant) continue to produce virus for extended periods of time, 
whereas H-2  d and H-2  k (susceptible) tumor lines shut-off virus production after 
shorter times in culture. These data suggest that H-2-1inked gene(s) may effect 
the stability of cellular transformation and virus replication. 
One  likely  mechanism for  resistance  to  RadLV-induced  leukemogenesis 
would be tumor surveillance via immunologically competent cells. However, 
preliminary studies  have  failed to  demonstrate a  correlation between H-2- 
associated resistance to RadLV and the capacity to respond via a humoral or 
cell-mediated immune response to RadLV or RadLV-infected tumor cells.  In 
view of this failure, and the mapping of loci conferring resistance to RadLV to 
the D region of the H-2 complex, it is provocative to ask whether genes within 
the major histocompatibility complex may affect susceptibility to virus-induced 
letlkemia by mechanisms distinct  from those previously associated with Ir 
genes. If such an alternative mechanism were found, it would have a  major 
influence on  current efforts to  understand HLA-associated susceptibility or 
resistance to a variety of diseases (27). Furthermore, as will be shown in the 
accompanying paper, it will be important to bear in mind that H-2-associated 
mechanisms of resistance can be modified by other genes within the mouse 
genome. 
Summary 
Resistance to radiation leukemia virus-induced leukemogenesis is associated 
with the H-2D region of the H-2 complex, or with closely linked loci. The H.2D  d 
allele confers resistance to the disease, while the H.2D  q and H-2D'  alleles are 
associated with susceptibility. It is not clear whether  Ir genes, or an alternative 
mechanism are responsible for the observed H-2-1inked  resistance to the dis- 
ease. 
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